SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Biotech makes equity investment of $1,500 in Stellon Biotech Inc

02 Jul 2025 Evaluate

Concord Biotech has made an equity investment of $1,500 in Stellon Biotech Inc, USA. This investment represents the subscription of 15 million equity shares at a price of $0.0001 per share resulting into 75% ownership in Stellon Biotech Inc. 

This investment has been made with the objective to expand business operations in USA for the company, through its own subsidiary with a local partner in the United States of America (USA). The company proposed to utilize this U.S. subsidiary to distribute and sell its products in USA.

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Concord Biotech Share Price

1067.40 -13.85 (-1.28%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×